Johnson & Johnson's vaccine is fourth to begin Phase 3 trials in US

Johnson & Johnson's Covid-19 vaccine candidate begins Phase 3 trials in the United States today. Trials for the single-dose vaccine will include up to 60,000 adult participants at nearly 215 sites in the US and internationally.

Click Here to read the entire article...